» Articles » PMID: 33419488

MiR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2

Overview
Journal Oncol Res
Specialty Oncology
Date 2021 Jan 9
PMID 33419488
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

This study was designed to investigate the precise mechanisms of miR-325-3p/S100A2 axis in breast cancer (BC). In this study, we found that the level of miR-325-3p was dramatically increased in BC tissues and cell lines, and the expression of S100A2 was significantly decreased. Also, the high level of miR-325-3p was closely associated with low expression of S100A2 in BC tissues. Moreover, introduction of miR-325-3p significantly promoted proliferation, invasion, and EMT of BC cells. Bioinformatics analysis predicted that the S100A2 was a potential target gene of miR-325-3p. Luciferase reporter assay demonstrated that miR-325-3p could directly target S100A2. In addition, miR-325-3p overexpression had similar effects with knockdown of S100A2 on BC cells. Overexpression of S100A2 in BC cells partially reversed the promoted effects of miR-325-3p mimic. Overexpression of miR-325-3p promoted cell proliferation, invasion, and EMT of BC cells by directly downregulating S100A2 expression.

Citing Articles

Gene expression profiling for the diagnosis of male breast cancer.

Liu J, Sun Y, Qi P, Wo Y, Pang Y, Xu Q BMC Cancer. 2024; 24(1):1584.

PMID: 39731080 PMC: 11681697. DOI: 10.1186/s12885-024-13358-4.


S100A2 activation promotes interstitial fibrosis in kidneys by FoxO1-mediated epithelial-mesenchymal transition.

Yang X, Zheng F, Yan P, Liu X, Chen X, Du X Cell Biol Toxicol. 2024; 40(1):86.

PMID: 39382800 PMC: 11464619. DOI: 10.1007/s10565-024-09929-7.


Single-cell analysis of breast cancer metastasis reveals epithelial-mesenchymal plasticity signatures associated with poor outcomes.

Winkler J, Tan W, Diadhiou C, McGinnis C, Abbasi A, Hasnain S J Clin Invest. 2024; 134(17).

PMID: 39225101 PMC: 11364385. DOI: 10.1172/JCI164227.


TFAP2A Activates S100A2 to Mediate Glutamine Metabolism and Promote Lung Adenocarcinoma Metastasis.

Zeng T, Ren W, Zeng H, Wang D, Wu X, Xu G Clin Respir J. 2024; 18(8):e13825.

PMID: 39187936 PMC: 11347387. DOI: 10.1111/crj.13825.


MicroRNA‑325: A comprehensive exploration of its multifaceted roles in cancer pathogenesis and therapeutic implications (Review).

Fu Z, Zhou Y, Zhang Y, Zhou Z, Yu Y, Yuan C Oncol Lett. 2024; 28(4):459.

PMID: 39119235 PMC: 11307554. DOI: 10.3892/ol.2024.14592.


References
1.
Liu Y, Liu Q, Wang X, Luo C . Clinical significance of S100A2 expression in gastric cancer. Tumour Biol. 2013; 35(4):3731-41. DOI: 10.1007/s13277-013-1495-3. View

2.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

3.
Ren Z, Yang T, Ding J, Liu W, Meng X, Zhang P . MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression. Am J Transl Res. 2018; 10(4):1097-1108. PMC: 5934569. View

4.
Jones S . Metastatic breast cancer: the treatment challenge. Clin Breast Cancer. 2008; 8(3):224-33. DOI: 10.3816/CBC.2008.n.025. View

5.
Bao S, Wang X, Wang Z, Yang J, Liu F, Yin C . MicroRNA-30 mediates cell invasion and metastasis in breast cancer. Biochem Cell Biol. 2018; 96(6):825-831. DOI: 10.1139/bcb-2018-0032. View